Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Obstructive Lung Diseases

  Free Subscription


Articles published in Eur Respir J

Retrieve available abstracts of 136 articles:
HTML format
Text format



Single Articles


    May 2017
  1. BUHL R, Humbert M, Bjermer L, Chanez P, et al
    Severe eosinophilic asthma: a roadmap to consensus.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  2. MIRAVITLLES M
    Diagnosis of asthma-COPD overlap: the five commandments.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  3. BOUSQUET J, Chavannes NH, Guldemond N, Haahtela T, et al
    Realising the potential of mHealth to improve asthma and allergy care: how to shape the future.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  4. MCDONALD VM, Gibson PG
    "To define is to limit": perspectives on asthma-COPD overlap syndrome and personalised medicine.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  5. HIMES BE, Ortega VE
    Making progress toward understanding the genetic architecture of asthma in the most affected US ethnic group.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  6. HERBERT C, Kumar RK
    Ambient air pollution and asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  7. MIRAVITLLES M, Alvarez-Gutierrez FJ, Calle M, Casanova C, et al
    Algorithm for identification of asthma-COPD overlap: consensus between the Spanish COPD and asthma guidelines.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  8. EDWARDS MR, Saglani S, Schwarze J, Skevaki C, et al
    Addressing unmet needs in understanding asthma mechanisms: From the European Asthma Research and Innovation Partnership (EARIP) Work Package (WP)2 collaborators.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  9. COSIO BG, Perez de Llano L, Lopez Vina A, Torrego A, et al
    Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome?
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  10. TOMMOLA M, Ilmarinen P, Tuomisto LE, Lehtimaki L, et al
    Differences between asthma-COPD overlap syndrome and adult-onset asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  11. MASEFIELD S, Edwards J, Hansen K, Hamerlijnck D, et al
    The future of asthma research and development: a roadmap from the European Asthma Research and Innovation Partnership (EARIP).
    Eur Respir J. 2017;49.
    PubMed     Text format    


  12. PAPADOPOULOS NG, Androutsopoulou A, Akdis C, Dahlen SE, et al
    Asthma research in Europe: a transformative agenda for innovation and competitiveness.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  13. KOURI A, Boulet LP, Kaplan A, Gupta S, et al
    An evidence-based, point-of-care tool to guide completion of asthma action plans in practice.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  14. THOMSON NC
    Asthma and smoking-induced airway disease without spirometric COPD.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  15. AZAD MB, Vehling L, Lu Z, Dai D, et al
    Breastfeeding, maternal asthma and wheezing in the first year of life: a longitudinal birth cohort study.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  16. BONTEN TN, Kasteleyn MJ, de Mutsert R, Hiemstra PS, et al
    Defining asthma-COPD overlap syndrome: a population-based study.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  17. SIMPSON AJ, Honkoop PJ, Kennington E, Snoeck-Stroband JB, et al
    Perspectives of patients and healthcare professionals on mHealth for asthma self-management.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  18. BERAIR R, Hartley R, Mistry V, Sheshadri A, et al
    Associations in asthma between quantitative computed tomography and bronchial biopsy-derived airway remodelling.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  19. YAN Q, Brehm J, Pino-Yanes M, Forno E, et al
    A meta-analysis of genome-wide association studies of asthma in Puerto Ricans.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  20. HTET TD, Teede HJ, de Courten B, Loxton D, et al
    Asthma in reproductive-aged women with polycystic ovary syndrome and association with obesity.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  21. OLVEIRA C, Martinez-Garcia MA
    Health-related quality of life questionnaires in bronchiectasis: the simplest way to quantify complexity.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  22. SPINOU A, Siegert RJ, Guan WJ, Patel AS, et al
    The development and validation of the Bronchiectasis Health Questionnaire.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  23. AAMLI GAGNAT A, Gjerdevik M, Gallefoss F, Coxson HO, et al
    Incidence of non-pulmonary cancer and lung cancer by amount of emphysema and airway wall thickness: a community-based cohort.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    April 2017
  24. VALLIERES E, Tumelty K, Tunney MM, Hannah R, et al
    Efficacy of Pseudomonas aeruginosa eradication regimens in bronchiectasis.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  25. HILLIAM Y, Moore MP, Lamont IL, Bilton D, et al
    Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  26. FRIJA-MASSON J, Martin C, Regard L, Lothe MN, et al
    Bacteria-driven peribronchial lymphoid neogenesis in bronchiectasis and cystic fibrosis.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    March 2017
  27. GRAS D, Martinez-Anton A, Bourdin A, Garulli C, et al
    Human bronchial epithelium orchestrates dendritic cell activation in severe asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  28. MUNOZ-CANO R, Torrego A, Bartra J, Sanchez-Lopez J, et al
    Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study).
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  29. DEBRAY MP, Dombret MC, Pretolani M, Thabut G, et al
    Early computed tomography modifications following bronchial thermoplasty in patients with severe asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  30. BERGAUER A, Sopel N, Kross B, Vuorinen T, et al
    Rhinovirus species/genotypes and interferon-lambda: subtypes, receptor and polymorphisms - missing pieces of the puzzle of childhood asthma?
    Eur Respir J. 2017;49.
    PubMed     Text format    


  31. SCAGNOLARI C, Midulla F, Nenna R, Papoff P, et al
    Rhinovirus species/genotypes and interferon-lambda: subtypes, receptor and polymorphisms - missing pieces of the puzzle of childhood asthma?
    Eur Respir J. 2017;49.
    PubMed     Text format    


  32. BERGAUER A, Sopel N, Kross B, Vuorinen T, et al
    IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  33. STERK PJ
    A good asthma catch by professional fishing.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  34. BARALDO S, Papi A, Saetta M, Contoli M, et al
    IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  35. REINKE SN, Gallart-Ayala H, Gomez C, Checa A, et al
    Metabolomics analysis identifies different metabotypes of asthma severity.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    February 2017
  36. PAPI A, Saetta M, Fabbri L
    Severe asthma: phenotyping to endotyping or vice versa?
    Eur Respir J. 2017;49.
    PubMed     Text format    


  37. KUO CS, Pavlidis S, Loza M, Baribaud F, et al
    T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  38. BRUMPTON B, Mai XM, Langhammer A, Laugsand LE, et al
    Prospective study of insomnia and incident asthma in adults: the HUNT study.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  39. ZOLLER B, Pirouzifard M, Memon AA, Sundquist J, et al
    Risk of pulmonary embolism and deep venous thrombosis in patients with asthma: a nationwide case-control study from Sweden.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    January 2017
  40. BAHMER T, Waschki B, Schatz F, Herzmann C, et al
    Physical activity, airway resistance and small airway dysfunction in severe asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  41. DE-TORRES JP, Sanchez-Salcedo P, Bastarrika G, Alcaide AB, et al
    Telomere length, COPD and emphysema as risk factors for lung cancer.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  42. GRIGG J
    Tiotropium in paediatric asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  43. ELLWOOD P, Asher MI, Billo NE, Bissell K, et al
    The Global Asthma Network rationale and methods for Phase I global surveillance: prevalence, severity, management and risk factors.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available



  44. ERJ January Podcast: the BioSHaRE approach to understanding of the effects of air pollution on asthma.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  45. ALIBERTI S, Dhar R, Aksamit TR, Morgan L, et al
    Additional important research priorities for bronchiectasis in China.
    Eur Respir J. 2017;49.
    PubMed     Text format    


  46. GUAN WJ, Gao YH, Yuan JJ, Chen RC, et al
    Additional important research priorities for bronchiectasis in China.
    Eur Respir J. 2017;49.
    PubMed     Text format    


    December 2016
  47. GAGA M, Zervas E, Humbert M
    Targeting immunoglobulin E in non-atopic asthma: crossing the red line?
    Eur Respir J. 2016;48:1538-1540.
    PubMed     Text format    


    November 2016
  48. BERGAUER A, Sopel N, Kross B, Vuorinen T, et al
    IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma.
    Eur Respir J. 2016 Nov 11. pii: ERJ-00969-2016. doi: 10.1183/13993003.00969-2016
    PubMed     Text format     Abstract available


  49. SHIN S, Park HY, Kim H, Kim HK, et al
    Joint effect of airflow limitation and emphysema on postoperative outcomes in early-stage nonsmall cell lung cancer.
    Eur Respir J. 2016 Nov 3. pii: ERJ-01148-2016. doi: 10.1183/13993003.01148-2016.
    PubMed     Text format     Abstract available


  50. HAMELMANN E, Bernstein JA, Vandewalker M, Moroni-Zentgraf P, et al
    A randomised controlled trial of tiotropium in adolescents with severe symptomatic asthma.
    Eur Respir J. 2016 Nov 3. pii: ERJ-01100-2016. doi: 10.1183/13993003.01100-2016.
    PubMed     Text format     Abstract available


  51. LEZMI G, Galmiche-Rolland L, Rioux S, Jaubert F, et al
    Mast cells are associated with exacerbations and eosinophilia in children with severe asthma.
    Eur Respir J. 2016;48:1320-1328.
    PubMed     Text format     Abstract available


  52. WILSON SJ, Ward JA, Sousa AR, Corfield J, et al
    Severe asthma exists despite suppressed tissue inflammation: findings of the U-BIOPRED study.
    Eur Respir J. 2016;48:1307-1319.
    PubMed     Text format     Abstract available


  53. FLEMING L, Saglani S, Bush A
    Asthma attacks: should we nail our colours to the mast (cell)?
    Eur Respir J. 2016;48:1261-1264.
    PubMed     Text format    


    October 2016
  54. CAI Y, Zijlema WL, Doiron D, Blangiardo M, et al
    Ambient air pollution, traffic noise and adult asthma prevalence: a BioSHaRE approach.
    Eur Respir J. 2016 Oct 20. pii: ERJ-02127-2015. doi: 10.1183/13993003.02127-2015
    PubMed     Text format     Abstract available


  55. PILLAI P, Chan YC, Wu SY, Ohm-Laursen L, et al
    Omalizumab reduces bronchial mucosal IgE and improves lung function in non-atopic asthma.
    Eur Respir J. 2016 Oct 20. pii: ERJ-01501-2015. doi: 10.1183/13993003.01501-2015
    PubMed     Text format     Abstract available


  56. CHEN YC, Liou TH, Chen PC, Chiang BL, et al
    Growth trajectories and asthma/rhinitis in children: a longitudinal study in Taiwan.
    Eur Respir J. 2016 Oct 20. pii: ERJ-00741-2016. doi: 10.1183/13993003.00741-2016
    PubMed     Text format     Abstract available


  57. CHEN W, Lynd LD, FitzGerald JM, Marra CA, et al
    Excess medical costs in patients with asthma and the role of comorbidity.
    Eur Respir J. 2016 Oct 6. pii: ERJ-01141-2016. doi: 10.1183/13993003.01141-2016.
    PubMed     Text format     Abstract available


  58. SCHWARZE J, Fitch PM, Heimweg J, Errington C, et al
    Viral mimic poly-(I:C) attenuates airway epithelial T-cell suppressive capacity: implications for asthma.
    Eur Respir J. 2016 Oct 6. pii: ERJ-00841-2016. doi: 10.1183/13993003.00841-2016.
    PubMed     Text format    


  59. MAGNUS MC, Haberg SE, Magnus P, Engeland A, et al
    Pre-eclampsia and childhood asthma.
    Eur Respir J. 2016 Oct 6. pii: ERJ-00673-2016. doi: 10.1183/13993003.00673-2016.
    PubMed     Text format     Abstract available


  60. MAO B, Yang JW, Lu HW, Xu JF, et al
    Asthma and risk of bronchiectasis exacerbation: we still need more evidence.
    Eur Respir J. 2016;48:1247-1248.
    PubMed     Text format    


  61. GAO YH, Guan WJ, Chen RC, Zhang GJ, et al
    Asthma and risk of bronchiectasis exacerbation: we still need more evidence.
    Eur Respir J. 2016;48:1246-1247.
    PubMed     Text format    


  62. POYNTER ME, Irvin CG
    Interleukin-6 as a biomarker for asthma: hype or is there something else?
    Eur Respir J. 2016;48:979-981.
    PubMed     Text format    


  63. HAMBLETON K, Pavord ID
    What can we learn from blood granulocyte patterns in patients with asthma?
    Eur Respir J. 2016;48:976-978.
    PubMed     Text format    


    September 2016
  64. TOMMOLA M, Ilmarinen P, Tuomisto LE, Haanpaa J, et al
    The effect of smoking on lung function: a clinical study of adult-onset asthma.
    Eur Respir J. 2016 Sep 22. pii: ERJ-00850-2016. doi: 10.1183/13993003.00850-2016
    PubMed     Text format     Abstract available



  65. ERJ September Podcast: research priorities in bronchiectasis.
    Eur Respir J. 2016;48:E69.
    PubMed     Text format    


  66. VAN DEN WIJNGAART LS, Roukema J, Merkus PJ
    Monitoring asthma: no matter how?
    Eur Respir J. 2016;48:614-6.
    PubMed     Text format    


  67. ROBINSON DS
    Assessing severe asthma.
    Eur Respir J. 2016;48:611-3.
    PubMed     Text format    


  68. GRAS D, Chanez P
    New sociology for better understanding severe eosinophilic asthma: introducing the SOCS family.
    Eur Respir J. 2016;48:608-10.
    PubMed     Text format    


  69. AHMADIZAR F, Vijverberg SJ, Arets HG, de Boer A, et al
    Childhood obesity in relation to poor asthma control and exacerbation: a meta-analysis.
    Eur Respir J. 2016 Sep 1. pii: ERJ-00766-2016. doi: 10.1183/13993003.00766-2016.
    PubMed     Text format     Abstract available


    August 2016
  70. ILMARINEN P, Tuomisto LE, Niemela O, Danielsson J, et al
    Comorbidities and elevated IL-6 associate with negative outcome in adult-onset asthma.
    Eur Respir J. 2016 Aug 18. pii: ERJ-02198-2015. doi: 10.1183/13993003.02198-2015
    PubMed     Text format     Abstract available


  71. NADIF R, Siroux V, Boudier A, le Moual N, et al
    Blood granulocyte patterns as predictors of asthma phenotypes in adults from the EGEA study.
    Eur Respir J. 2016 Aug 4. pii: ERJ-00336-2016. doi: 10.1183/13993003.00336-2016.
    PubMed     Text format     Abstract available


  72. LEHTIMAKI L, Csonka P, Makinen E, Isojarvi J, et al
    Predictive value of exhaled nitric oxide in the management of asthma: a systematic review.
    Eur Respir J. 2016 Aug 4. pii: ERJ-00699-2016. doi: 10.1183/13993003.00699-2016.
    PubMed     Text format     Abstract available


  73. KING GG, Thamrin C
    Complex lung function in severe asthma: seeing is believing.
    Eur Respir J. 2016;48:294-6.
    PubMed     Text format    


  74. PETERS MC, Fahy JV
    Metabolic consequences of obesity as an "outside in" mechanism of disease severity in asthma.
    Eur Respir J. 2016;48:291-3.
    PubMed     Text format    


  75. BARALDO S, Turato G, Cosio MG, Saetta M, et al
    Which CD8+ T-cells in asthma? Attacking or defending?
    Eur Respir J. 2016;48:287-90.
    PubMed     Text format    


    July 2016
  76. USEMANN J, Fuchs O, Anagnostopoulou P, Korten I, et al
    Predictive value of exhaled nitric oxide in healthy infants for asthma at school age.
    Eur Respir J. 2016 Jul 7. pii: ERJ-00439-2016. doi: 10.1183/13993003.00439-2016.
    PubMed     Text format    



  77. "Tidal flow variability measured by impedance pneumography relates to childhood asthma risk." Ville-Pekka Seppa, Anna S. Pelkonen, Anne Kotaniemi-Syrjanen, Jari Viik, Mika J. Makela and L. Pekka Malmberg. Eur Respir J 2016; 47: 1687-1696.
    Eur Respir J. 2016;48:285.
    PubMed     Text format    


    June 2016
  78. VAN DER MEER AN, Pasma H, Kempenaar-Okkema W, Pelinck JA, et al
    A 1-day visit in a severe asthma centre: effect on asthma control, quality of life and healthcare use.
    Eur Respir J. 2016 Jun 23. pii: ERJ-00220-2016. doi: 10.1183/13993003.00220-2016
    PubMed     Text format     Abstract available


  79. SIN DD, Miravitlles M, Mannino DM, Soriano JB, et al
    What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion.
    Eur Respir J. 2016 Jun 23. pii: ERJ-00436-2016. doi: 10.1183/13993003.00436-2016
    PubMed     Text format     Abstract available


  80. DORAN E, Choy DF, Shikotra A, Butler CA, et al
    Reduced epithelial suppressor of cytokine signalling 1 in severe eosinophilic asthma.
    Eur Respir J. 2016 Jun 23. pii: ERJ-00400-2015. doi: 10.1183/13993003.00400-2015
    PubMed     Text format     Abstract available


  81. FISHER JA, Puett RC, Hart JE, Camargo CA Jr, et al
    Particulate matter exposures and adult-onset asthma and COPD in the Nurses' Health Study.
    Eur Respir J. 2016 Jun 10. pii: ERJ-00845-2015. doi: 10.1183/13993003.00845-2015
    PubMed     Text format    


  82. ALIBERTI S, Masefield S, Polverino E, De Soyza A, et al
    Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration.
    Eur Respir J. 2016 Jun 10. pii: ERJ-01888-2015. doi: 10.1183/13993003.01888-2015
    PubMed     Text format     Abstract available



  83. "Asthma inhaler adherence determinants in adults: systematic review of observational data." Alexandra L. Dima, Gimena Hernandez, Oriol Cunillera, Montserrat Ferrer, Marijn de Bruin and the ASTRO-LAB group. Eur Respir J 2015; 45: 994-1018.
    Eur Respir J. 2016;47:1892.
    PubMed     Text format    


  84. SORIANO JB, Serrano J
    Bronchiectasthma and asthmectasis!
    Eur Respir J. 2016;47:1597-600.
    PubMed     Text format    


    May 2016
  85. DEN OTTER I, Willems LN, van Schadewijk A, van Wijngaarden S, et al
    Lung function decline in asthma patients with elevated bronchial CD8, CD4 and CD3 cells.
    Eur Respir J. 2016 May 26. pii: ERJ-01525-2015. doi: 10.1183/13993003.01525-2015
    PubMed     Text format     Abstract available


  86. SUBRAMANIAN DR, Gupta S, Burggraf D, Vom Silberberg SJ, et al
    Emphysema- and airway-dominant COPD phenotypes defined by standardised quantitative computed tomography.
    Eur Respir J. 2016 May 26. pii: ERJ-01878-2015. doi: 10.1183/13993003.01878-2015
    PubMed     Text format     Abstract available


  87. DUCHARME FM, Gagnon R, Benard B, Tse SM, et al
    Cessation of long-acting beta2-agonist in children with persistent asthma on inhaled corticosteroids.
    Eur Respir J. 2016 May 26. pii: ERJ-00014-2016. doi: 10.1183/13993003.00014-2016
    PubMed     Text format    


  88. VASBINDER EC, Goossens LM, Rutten-van Molken MP, de Winter BC, et al
    e-Monitoring of Asthma Therapy to Improve Compliance in children (e-MATIC): a randomised controlled trial.
    Eur Respir J. 2016 May 26. pii: ERJ-01698-2015. doi: 10.1183/13993003.01698-2015
    PubMed     Text format     Abstract available


  89. CHIH AH, Chen YC, Tu YK, Huang KC, et al
    Mediating pathways from central obesity to childhood asthma: a population-based longitudinal study.
    Eur Respir J. 2016 May 12. pii: ERJ-00226-2016. doi: 10.1183/13993003.00226-2016
    PubMed     Text format     Abstract available


  90. SVENNINGSEN S, Nair P, Guo F, McCormack DG, et al
    Is ventilation heterogeneity related to asthma control?
    Eur Respir J. 2016 May 12. pii: ERJ-00393-2016. doi: 10.1183/13993003.00393-2016
    PubMed     Text format     Abstract available


    April 2016
  91. LUM S, Stocks J
    Inclusion of children with airway disease for the development of spirometry reference data.
    Eur Respir J. 2016;47:1292-3.
    PubMed     Text format    


  92. HULS A, Kramer U, Schuster A, Gappa M, et al
    Inclusion of children with airway disease for the development of spirometry reference data.
    Eur Respir J. 2016;47:1290-2.
    PubMed     Text format    


  93. GOMEZ C, Chanez P
    The lung microbiome: the perfect culprit for COPD exacerbations?
    Eur Respir J. 2016;47:1034-6.
    PubMed     Text format    


  94. BOUSQUET J, Barbara C, Bateman E, Bel E, et al
    AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation.
    Eur Respir J. 2016;47:1028-33.
    PubMed     Text format    


  95. SPRUIT MA, Franssen FM, Rutten EP, Wopereis S, et al
    A new perspective on COPD exacerbations: monitoring impact by measuring physical, psychological and social resilience.
    Eur Respir J. 2016;47:1024-7.
    PubMed     Text format    


  96. COSTA C, Traves SL, Tudhope SJ, Fenwick PS, et al
    Enhanced monocyte migration to CXCR3 and CCR5 chemokines in COPD.
    Eur Respir J. 2016;47:1093-102.
    PubMed     Text format     Abstract available


  97. CHARUSUSIN N, Gosselink R, McConnell A, Demeyer H, et al
    Inspiratory muscle training improves breathing pattern during exercise in COPD patients.
    Eur Respir J. 2016;47:1261-4.
    PubMed     Text format    


  98. WANG Z, Bafadhel M, Haldar K, Spivak A, et al
    Lung microbiome dynamics in COPD exacerbations.
    Eur Respir J. 2016;47:1082-92.
    PubMed     Text format     Abstract available


  99. DIZIER MH, Nadif R, Margaritte-Jeannin P, Barton SJ, et al
    Interaction between the DNAH9 gene and early smoke exposure in bronchial hyperresponsiveness.
    Eur Respir J. 2016;47:1072-81.
    PubMed     Text format     Abstract available


  100. MUMBY S, Saito J, Adcock IM, Chung KF, et al
    Decreased breath excretion of redox active iron in COPD: a protective failure?
    Eur Respir J. 2016;47:1267-70.
    PubMed     Text format    


    March 2016
  101. KOLAHIAN S, Oz HH, Zhou B, Griessinger CM, et al
    The emerging role of myeloid-derived suppressor cells in lung diseases.
    Eur Respir J. 2016;47:967-77.
    PubMed     Text format     Abstract available


  102. BARTOLI ML, Costa F, Malagrino L, Nieri D, et al
    Sputum inflammatory cells in COPD patients classified according to GOLD 2011 guidelines.
    Eur Respir J. 2016;47:978-80.
    PubMed     Text format    


  103. ZAIGHAM S, Wollmer P, Engstrom G
    Lung function, forced expiratory volume in 1 s decline and COPD hospitalisations over 44 years of follow-up.
    Eur Respir J. 2016;47:742-50.
    PubMed     Text format     Abstract available


    February 2016
  104. BOLAND AC, Hodgekiss C, Hicks F, Edwards A, et al
    Improving end-of-life communication between primary and secondary care within respiratory medicine.
    Eur Respir J. 2016;47:658-60.
    PubMed     Text format    


  105. MOSS RB
    Treating allergic bronchopulmonary aspergillosis: the way forward.
    Eur Respir J. 2016;47:385-7.
    PubMed     Text format    


  106. SORIANO JB, Suissa S
    Ageing lungs and very elderly COPD: anytime and anywhere.
    Eur Respir J. 2016;47:379-81.
    PubMed     Text format    


  107. LANKEIT M, Held M
    Incidence of venous thromboembolism in COPD: linking inflammation and thrombosis?
    Eur Respir J. 2016;47:369-73.
    PubMed     Text format    


  108. AGUSTI A, Bel E, Thomas M, Vogelmeier C, et al
    Treatable traits: toward precision medicine of chronic airway diseases.
    Eur Respir J. 2016;47:410-9.
    PubMed     Text format     Abstract available


  109. PUENTE-MAESTU L, Palange P, Casaburi R, Laveneziana P, et al
    Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement.
    Eur Respir J. 2016;47:429-60.
    PubMed     Text format     Abstract available


  110. MIRAVITLLES M, Vogelmeier C, Roche N, Halpin D, et al
    A review of national guidelines for management of COPD in Europe.
    Eur Respir J. 2016;47:625-37.
    PubMed     Text format     Abstract available


  111. RODRIGUEZ-ROISIN R, Bartolome SD, Huchon G, Krowka MJ, et al
    Inflammatory bowel diseases, chronic liver diseases and the lung.
    Eur Respir J. 2016;47:638-50.
    PubMed     Text format     Abstract available


  112. LUOTO JA, Elmstahl S, Wollmer P, Pihlsgard M, et al
    Incidence of airflow limitation in subjects 65-100 years of age.
    Eur Respir J. 2016;47:461-72.
    PubMed     Text format     Abstract available


  113. BORVIK T, Braekkan SK, Enga K, Schirmer H, et al
    COPD and risk of venous thromboembolism and mortality in a general population.
    Eur Respir J. 2016;47:473-81.
    PubMed     Text format     Abstract available


  114. MAGNUSSEN H, Tetzlaff K, Bateman ED, Watz H, et al
    Lung function changes over time following withdrawal of inhaled corticosteroids in patients with severe COPD.
    Eur Respir J. 2016;47:651-4.
    PubMed     Text format    


  115. GARDEN FL, Simpson JM, Mellis CM, Marks GB, et al
    Change in the manifestations of asthma and asthma-related traits in childhood: a latent transition analysis.
    Eur Respir J. 2016;47:499-509.
    PubMed     Text format     Abstract available


    January 2016
  116. ELLIOTT L, von Essen S
    COPD in farmers: what have we learnt?
    Eur Respir J. 2016;47:16-8.
    PubMed     Text format    


  117. SANSORES RH, Ramirez-Venegas A
    COPD in women: susceptibility or vulnerability?
    Eur Respir J. 2016;47:19-22.
    PubMed     Text format    


  118. WELTE T
    Acute exacerbation in COPD: we must do more.
    Eur Respir J. 2016;47:14-5.
    PubMed     Text format    


  119. LAHOUSSE L, Moyse E, Krantic S, Brusselle GG, et al
    Understanding age-related diseases: report of the 2015 Ageing Summit.
    Eur Respir J. 2016;47:5-9.
    PubMed     Text format    


  120. SHAHEEN SO, Macdonald-Wallis C, Lawlor DA, Henderson AJ, et al
    Hypertensive disorders of pregnancy, respiratory outcomes and atopy in childhood.
    Eur Respir J. 2016;47:156-65.
    PubMed     Text format     Abstract available


  121. HARTL S, Lopez-Campos JL, Pozo-Rodriguez F, Castro-Acosta A, et al
    Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit.
    Eur Respir J. 2016;47:113-21.
    PubMed     Text format     Abstract available


  122. GUILLIEN A, Puyraveau M, Soumagne T, Guillot S, et al
    Prevalence and risk factors for COPD in farmers: a cross-sectional controlled study.
    Eur Respir J. 2016;47:95-103.
    PubMed     Text format     Abstract available


  123. CURROW DC, Abernethy AP, Allcroft P, Banzett RB, et al
    The need to research refractory breathlessness.
    Eur Respir J. 2016;47:342-3.
    PubMed     Text format    


  124. LEAHY TR, McManus R, Doherty DG, Grealy R, et al
    Interleukin-15 is associated with disease severity in viral bronchiolitis.
    Eur Respir J. 2016;47:212-22.
    PubMed     Text format     Abstract available


  125. LAZAR Z, Mullner N, Lucattelli M, Ayata CK, et al
    NTPDase1/CD39 and aberrant purinergic signalling in the pathogenesis of COPD.
    Eur Respir J. 2016;47:254-63.
    PubMed     Text format     Abstract available


  126. MOTTE S, Melot C, Di Pierdomenico L, Martins D, et al
    Predictors of costs from the hospital perspective of primary pulmonary embolism.
    Eur Respir J. 2016;47:203-11.
    PubMed     Text format     Abstract available


  127. RADEMACHER J, Schulz A, Hedtfeld S, Stanke F, et al
    Nasal potential difference of carriers of the W493R ENaC variant with non-cystic fibrosis bronchiectasis.
    Eur Respir J. 2016;47:322-4.
    PubMed     Text format    


  128. GABROVSKA M, Lacombe E, Bruyneel M, Ninane V, et al
    Acute bronchospasm during passive exposure to bronchial provocation tests.
    Eur Respir J. 2016;47:320-2.
    PubMed     Text format    


  129. YANG JY, Oh SY, Song JW, Shim TS, et al
    Restrictive chronic lung function decline after haematopoietic stem cell transplantation.
    Eur Respir J. 2016;47:336-9.
    PubMed     Text format    


  130. SUISSA S
    Number needed to treat: enigmatic results for exacerbations in COPD.
    Eur Respir J. 2016;47:354-5.
    PubMed     Text format    


  131. LETTIS S, Keene O
    Number needed to treat: enigmatic results for exacerbations in COPD.
    Eur Respir J. 2016;47:353-4.
    PubMed     Text format    


    December 2015
  132. POPOVIC M, Rusconi F, Zugna D, Galassi C, et al
    Prenatal exposure to antibiotics and wheezing in infancy: a birth cohort study.
    Eur Respir J. 2015 Dec 2. pii: ERJ-00315-2015. doi: 10.1183/13993003.00315-2015.
    PubMed     Text format     Abstract available


    October 2015
  133. COX DW, Mullane D, Zhang GC, Turner SW, et al
    Longitudinal assessment of airway responsiveness from 1 month to 18 years in the PIAF birth cohort.
    Eur Respir J. 2015 Oct 22. pii: ERJ-00397-2015. doi: 10.1183/13993003.00397-2015
    PubMed     Text format     Abstract available


  134. YAMMINE S, Schmidt A, Sutter O, Fouzas S, et al
    Functional evidence for continued alveolarisation in former preterms at school age?
    Eur Respir J. 2015 Oct 22. pii: ERJ-00478-2015. doi: 10.1183/13993003.00478-2015
    PubMed     Text format     Abstract available


    August 2015
  135. MCKEON NJ, Timmins SN, Stewart H, Yerkovich ST, et al
    Diagnosis of COPD before cardiac surgery.
    Eur Respir J. 2015 Aug 20. pii: ERJ-02339-2014. doi: 10.1183/13993003.02339-2014
    PubMed     Text format    


    July 2015
  136. GAUVREAU GM, El-Gammal AI, O'Byrne PM
    Allergen-induced airway responses.
    Eur Respir J. 2015 Jul 23. pii: ERJ-00536-2015. doi: 10.1183/13993003.00536-2015
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: